Prestige consumer healthcare completes acquisition of theratears, announces first quarter fiscal 2022 earnings results date

Tarrytown, n.y., july 01, 2021 (globe newswire) -- prestige consumer healthcare inc. (nyse:pbh) (“prestige“ or the “company”) today announced that it has completed the previously announced acquisition of theratears and other over-the-counter consumer brands.   the closing was finalized pursuant to the terms of the asset purchase agreement which was initially announced on may 27, 2021, under which prestige agreed to acquire the brands from specialty pharmaceutical company, akorn operating company llc (“akorn”), for $230 million in cash. the acquisition of theratears will further enhance prestige's leading eye care portfolio and generate additional long-term growth opportunities for the company.
PBH Ratings Summary
PBH Quant Ranking